Shanghai Fosun Pharmaceutical Group Co 주식 주식분석 | 주식가격 | 뉴스 | 600196.SS | CNE000000X38 |

날짜	Shanghai Fosun Pharmaceutical Group Co 주식 가격
	26.51 undefined
	26.60 undefined
	26.68 undefined
	26.04 undefined
	26.50 undefined
	26.05 undefined
	25.68 undefined
	25.81 undefined
	25.82 undefined
	25.42 undefined
	25.45 undefined
	24.65 undefined
	24.88 undefined
	25.30 undefined
	25.76 undefined
	25.72 undefined
	26.58 undefined
	26.78 undefined
	29.20 undefined

날짜	Shanghai Fosun Pharmaceutical Group Co 매출	Shanghai Fosun Pharmaceutical Group Co EBIT	Shanghai Fosun Pharmaceutical Group Co 이익
2026e	48.72 조. undefined	3.26 조. undefined	3.23 조. undefined
2025e	46.62 조. undefined	3.15 조. undefined	2.76 조. undefined
2024e	42.86 조. undefined	2.86 조. undefined	2.31 조. undefined
2023	41.4 조. undefined	1.29 조. undefined	2.39 조. undefined
2022	43.95 조. undefined	3.5 조. undefined	3.73 조. undefined
2021	39.01 조. undefined	2.55 조. undefined	4.74 조. undefined
2020	30.31 조. undefined	2.64 조. undefined	3.66 조. undefined
2019	28.59 조. undefined	2.49 조. undefined	3.32 조. undefined
2018	24.92 조. undefined	2.29 조. undefined	2.71 조. undefined
2017	18.53 조. undefined	2.24 조. undefined	3.12 조. undefined
2016	14.63 조. undefined	1.64 조. undefined	2.81 조. undefined
2015	12.61 조. undefined	1.36 조. undefined	2.46 조. undefined
2014	12.03 조. undefined	1.11 조. undefined	2.11 조. undefined
2013	10 조. undefined	1.03 조. undefined	1.58 조. undefined
2012	7.34 조. undefined	553 백만 undefined	1.56 조. undefined
2011	6.49 조. undefined	324 백만 undefined	1.17 조. undefined
2010	4.56 조. undefined	163 백만 undefined	864 백만 undefined
2009	3.87 조. undefined	157 백만 undefined	2.5 조. undefined
2008	3.77 조. undefined	118 백만 undefined	691 백만 undefined
2007	3.69 조. undefined	164 백만 undefined	626 백만 undefined
2006	4.08 조. undefined	92 백만 undefined	258 백만 undefined
2005	2.99 조. undefined	143 백만 undefined	159 백만 undefined
2004	2.43 조. undefined	153 백만 undefined	215 백만 undefined

	매출	EBIT	이익
2004	2.43 조. CNY	153 백만 CNY	215 백만 CNY
2005	2.99 조. CNY	143 백만 CNY	159 백만 CNY
2006	4.08 조. CNY	92 백만 CNY	258 백만 CNY
2007	3.69 조. CNY	164 백만 CNY	626 백만 CNY
2008	3.77 조. CNY	118 백만 CNY	691 백만 CNY
2009	3.87 조. CNY	157 백만 CNY	2.5 조. CNY
2010	4.56 조. CNY	163 백만 CNY	864 백만 CNY
2011	6.49 조. CNY	324 백만 CNY	1.17 조. CNY
2012	7.34 조. CNY	553 백만 CNY	1.56 조. CNY
2013	10 조. CNY	1.03 조. CNY	1.58 조. CNY
2014	12.03 조. CNY	1.11 조. CNY	2.11 조. CNY
2015	12.61 조. CNY	1.36 조. CNY	2.46 조. CNY
2016	14.63 조. CNY	1.64 조. CNY	2.81 조. CNY
2017	18.53 조. CNY	2.24 조. CNY	3.12 조. CNY
2018	24.92 조. CNY	2.29 조. CNY	2.71 조. CNY
2019	28.59 조. CNY	2.49 조. CNY	3.32 조. CNY
2020	30.31 조. CNY	2.64 조. CNY	3.66 조. CNY
2021	39.01 조. CNY	2.55 조. CNY	4.74 조. CNY
2022	43.95 조. CNY	3.5 조. CNY	3.73 조. CNY
2023	41.4 조. CNY	1.29 조. CNY	2.39 조. CNY
2024e	42.86 조. CNY	2.86 조. CNY	2.31 조. CNY
2025e	46.62 조. CNY	3.15 조. CNY	2.76 조. CNY
2026e	48.72 조. CNY	3.26 조. CNY	3.23 조. CNY

Shanghai Fosun Pharmaceutical Group Co 브루토마진	Shanghai Fosun Pharmaceutical Group Co 이익 마진	Shanghai Fosun Pharmaceutical Group Co EBIT-마진	Shanghai Fosun Pharmaceutical Group Co 이익 마진
2026e	47.54 %	6.69 %	6.62 %
2025e	47.54 %	6.76 %	5.92 %
2024e	47.54 %	6.68 %	5.4 %
2023	47.54 %	3.11 %	5.76 %
2022	47.09 %	7.97 %	8.49 %
2021	47.97 %	6.54 %	12.14 %
2020	55.47 %	8.72 %	12.09 %
2019	59.57 %	8.71 %	11.62 %
2018	58.34 %	9.17 %	10.87 %
2017	58.84 %	12.06 %	16.86 %
2016	53.81 %	11.23 %	19.18 %
2015	49.78 %	10.81 %	19.51 %
2014	43.87 %	9.19 %	17.57 %
2013	44.22 %	10.3 %	15.84 %
2012	43.62 %	7.53 %	21.31 %
2011	37.63 %	5 %	17.98 %
2010	33.9 %	3.58 %	18.97 %
2009	32.02 %	4.05 %	64.51 %
2008	27.67 %	3.13 %	18.31 %
2007	26.59 %	4.44 %	16.95 %
2006	21.34 %	2.25 %	6.32 %
2005	29.98 %	4.78 %	5.32 %
2004	31.22 %	6.31 %	8.87 %

	브루토마진	EBIT-마진	이익 마진
2004	31.22 %	6.31 %	8.87 %
2005	29.98 %	4.78 %	5.32 %
2006	21.34 %	2.25 %	6.32 %
2007	26.59 %	4.44 %	16.95 %
2008	27.67 %	3.13 %	18.31 %
2009	32.02 %	4.05 %	64.51 %
2010	33.9 %	3.58 %	18.97 %
2011	37.63 %	5 %	17.98 %
2012	43.62 %	7.53 %	21.31 %
2013	44.22 %	10.3 %	15.84 %
2014	43.87 %	9.19 %	17.57 %
2015	49.78 %	10.81 %	19.51 %
2016	53.81 %	11.23 %	19.18 %
2017	58.84 %	12.06 %	16.86 %
2018	58.34 %	9.17 %	10.87 %
2019	59.57 %	8.71 %	11.62 %
2020	55.47 %	8.72 %	12.09 %
2021	47.97 %	6.54 %	12.14 %
2022	47.09 %	7.97 %	8.49 %
2023	47.54 %	3.11 %	5.76 %
2024e	47.54 %	6.68 %	5.4 %
2025e	47.54 %	6.76 %	5.92 %
2026e	47.54 %	6.69 %	6.62 %

날짜	Shanghai Fosun Pharmaceutical Group Co 주당 매출	Shanghai Fosun Pharmaceutical Group Co EBIT 당 주식	Shanghai Fosun Pharmaceutical Group Co 주당 이익
2026e	23.09 undefined	0 undefined	1.53 undefined
2025e	22.09 undefined	0 undefined	1.31 undefined
2024e	20.31 undefined	0 undefined	1.1 undefined
2023	15.51 undefined	0.48 undefined	0.89 undefined
2022	16.86 undefined	1.34 undefined	1.43 undefined
2021	15.22 undefined	1 undefined	1.85 undefined
2020	11.82 undefined	1.03 undefined	1.43 undefined
2019	11.15 undefined	0.97 undefined	1.3 undefined
2018	9.88 undefined	0.91 undefined	1.07 undefined
2017	7.53 undefined	0.91 undefined	1.27 undefined
2016	6.28 undefined	0.71 undefined	1.2 undefined
2015	5.43 undefined	0.59 undefined	1.06 undefined
2014	5.24 undefined	0.48 undefined	0.92 undefined
2013	4.46 undefined	0.46 undefined	0.71 undefined
2012	3.28 undefined	0.25 undefined	0.7 undefined
2011	3.41 undefined	0.17 undefined	0.61 undefined
2010	2.42 undefined	0.09 undefined	0.46 undefined
2009	2.09 undefined	0.08 undefined	1.35 undefined
2008	2.03 undefined	0.06 undefined	0.37 undefined
2007	1.99 undefined	0.09 undefined	0.34 undefined
2006	2.2 undefined	0.05 undefined	0.14 undefined
2005	1.84 undefined	0.09 undefined	0.1 undefined
2004	1.5 undefined	0.09 undefined	0.13 undefined

	주당 매출	EBIT 당 주식	주당 이익
2004	1.5 CNY	0.09 CNY	0.13 CNY
2005	1.84 CNY	0.09 CNY	0.1 CNY
2006	2.2 CNY	0.05 CNY	0.14 CNY
2007	1.99 CNY	0.09 CNY	0.34 CNY
2008	2.03 CNY	0.06 CNY	0.37 CNY
2009	2.09 CNY	0.08 CNY	1.35 CNY
2010	2.42 CNY	0.09 CNY	0.46 CNY
2011	3.41 CNY	0.17 CNY	0.61 CNY
2012	3.28 CNY	0.25 CNY	0.7 CNY
2013	4.46 CNY	0.46 CNY	0.71 CNY
2014	5.24 CNY	0.48 CNY	0.92 CNY
2015	5.43 CNY	0.59 CNY	1.06 CNY
2016	6.28 CNY	0.71 CNY	1.2 CNY
2017	7.53 CNY	0.91 CNY	1.27 CNY
2018	9.88 CNY	0.91 CNY	1.07 CNY
2019	11.15 CNY	0.97 CNY	1.3 CNY
2020	11.82 CNY	1.03 CNY	1.43 CNY
2021	15.22 CNY	1 CNY	1.85 CNY
2022	16.86 CNY	1.34 CNY	1.43 CNY
2023	15.51 CNY	0.48 CNY	0.89 CNY
2024e	20.31 CNY	0 CNY	1.1 CNY
2025e	22.09 CNY	0 CNY	1.31 CNY
2026e	23.09 CNY	0 CNY	1.53 CNY

	주식 수량
2004	1.61 조. Aktien
2005	1.62 조. Aktien
2006	1.86 조. Aktien
2007	1.86 조. Aktien
2008	1.86 조. Aktien
2009	1.86 조. Aktien
2010	1.89 조. Aktien
2011	1.9 조. Aktien
2012	2.24 조. Aktien
2013	2.24 조. Aktien
2014	2.3 조. Aktien
2015	2.32 조. Aktien
2016	2.33 조. Aktien
2017	2.46 조. Aktien
2018	2.52 조. Aktien
2019	2.56 조. Aktien
2020	2.56 조. Aktien
2021	2.56 조. Aktien
2022	2.61 조. Aktien
2023	2.67 조. Aktien
2024e	2.67 조. Aktien
2025e	2.67 조. Aktien
2026e	2.67 조. Aktien

날짜	Shanghai Fosun Pharmaceutical Group Co 배당금
2026e	0.44 undefined
2025e	0.44 undefined
2024e	0.44 undefined
2023	0.42 undefined
2022	0.56 undefined
2021	0.43 undefined
2020	0.39 undefined
2019	0.32 undefined
2018	0.38 undefined
2017	0.35 undefined
2016	0.32 undefined
2015	0.28 undefined
2014	0.27 undefined
2013	0.21 undefined
2012	0.1 undefined
2011	0.1 undefined
2010	0.07 undefined
2009	0.07 undefined
2008	0.07 undefined
2007	0.05 undefined
2006	0.17 undefined
2005	0.08 undefined
2004	0.1 undefined

	배당금	배당금 (추정)
2004	0.1 CNY	0 CNY
2005	0.08 CNY	0 CNY
2006	0.17 CNY	0 CNY
2007	0.05 CNY	0 CNY
2008	0.07 CNY	0 CNY
2009	0.07 CNY	0 CNY
2010	0.07 CNY	0 CNY
2011	0.1 CNY	0 CNY
2012	0.1 CNY	0 CNY
2013	0.21 CNY	0 CNY
2014	0.27 CNY	0 CNY
2015	0.28 CNY	0 CNY
2016	0.32 CNY	0 CNY
2017	0.35 CNY	0 CNY
2018	0.38 CNY	0 CNY
2019	0.32 CNY	0 CNY
2020	0.39 CNY	0 CNY
2021	0.43 CNY	0 CNY
2022	0.56 CNY	0 CNY
2023	0.42 CNY	0 CNY
2024e	0 CNY	0.44 CNY
2025e	0 CNY	0.44 CNY
2026e	0 CNY	0.44 CNY

날짜	Shanghai Fosun Pharmaceutical Group Co 배당률
2026e	31.31 %
2025e	33.27 %
2024e	30.77 %
2023	29.89 %
2022	39.14 %
2021	23.27 %
2020	27.27 %
2019	24.62 %
2018	35.51 %
2017	27.56 %
2016	26.67 %
2015	26.42 %
2014	29.35 %
2013	29.58 %
2012	14.29 %
2011	16.39 %
2010	14.49 %
2009	4.94 %
2008	18.02 %
2007	15.08 %
2006	124.54 %
2005	76.92 %
2004	78.9 %

	배당률
2004	78.9 %
2005	76.92 %
2006	124.54 %
2007	15.08 %
2008	18.02 %
2009	4.94 %
2010	14.49 %
2011	16.39 %
2012	14.29 %
2013	29.58 %
2014	29.35 %
2015	26.42 %
2016	26.67 %
2017	27.56 %
2018	35.51 %
2019	24.62 %
2020	27.27 %
2021	23.27 %
2022	39.14 %
2023	29.89 %
2024e	30.77 %
2025e	33.27 %
2026e	31.31 %

EPS-예상치	EPS-실제	보고 분기
0.28	0.23 (-18.67 %)	2024 Q2
0.35	0.23 (-34 %)	2024 Q1
0.41	0.04 (-90.22 %)	2023 Q4
0.39	0.19 (-52.79 %)	2023 Q3
0.33	0.3 (-8.62 %)	2023 Q2
0.38	0.37 (-3.6 %)	2023 Q1
0.38	0.48 (26.72 %)	2022 Q4
0.41	0.34 (-16.89 %)	2022 Q3
0.43	0.42 (-2.17 %)	2022 Q2
0.37	0.18 (-51.83 %)	2022 Q1
0.34	0.46 (33.95 %)	2021 Q4
0.47	0.42 (-11.52 %)	2021 Q3
0.96	0.33 (-65.61 %)	2021 Q2
0.34	0.33 (-3.9 %)	2021 Q1
0.44	0.46 (3.51 %)	2020 Q4
0.31	0.3 (-4.18 %)	2020 Q3
0.36	0.44 (22.7 %)	2020 Q2
0.22	0.23 (6.73 %)	2020 Q1
0.63	0.49 (-22.58 %)	2019 Q4
0.29	0.22 (-23.58 %)	2019 Q3
0.35	0.31 (-11.28 %)	2019 Q2
0.33	0.28 (-14.71 %)	2019 Q1
0.27	0.24 (-11.99 %)	2018 Q4
0.35	0.2 (-43.42 %)	2018 Q3
0.4	0.35 (-13.37 %)	2018 Q2
0.33	0.28 (-15.99 %)	2018 Q1
0.32	0.28 (-13.06 %)	2017 Q4
0.31	0.29 (-7.53 %)	2017 Q3
0.41	0.39 (-4.53 %)	2017 Q2
0.31	0.31 (0.62 %)	2017 Q1
0.29	0.26 (-11.23 %)	2016 Q4
0.31	0.29 (-5.35 %)	2016 Q3
0.35	0.37 (5.87 %)	2016 Q2
0.28	0.27 (-4.53 %)	2016 Q1
0.28	0.24 (-13.61 %)	2015 Q4
0.3	0.25 (-17.49 %)	2015 Q3
0.28	0.33 (16.69 %)	2015 Q2
0.24	0.23 (-5.12 %)	2015 Q1
0.28	0.23 (-19.1 %)	2014 Q4
0.29	0.24 (-16.03 %)	2014 Q3
0.34	0.25 (-25.04 %)	2014 Q2
0.09	0.05 (-44.88 %)	2011 Q4

%-지분	이름	주식	변경
45.55898 %	Shanghai Fosun High Technology (Group) Co., Ltd.	961,424,455	75,108,500
1.83559 %	China Securities Finance Corporation Ltd.	38,736,079	38,736,079
1.44455 %	Dacheng Fund Management Co., Ltd.	30,484,035	0
1.11524 %	China Merchants Fund Management Co. Ltd.	23,534,818	-681,100
0.89042 %	E Fund Management Co. Ltd.	18,790,425	870,800
0.70250 %	Huatai-PineBridge Fund Management Co., Ltd.	14,824,825	1,253,000
0.49634 %	Yinhua Fund Management Co., Ltd.	10,474,235	-158,500
0.44755 %	China Universal Asset Management Co., Ltd.	9,444,537	288,000
0.39699 %	Tianhong Asset Management Co., Ltd.	8,377,592	938,400
0.38759 %	GF Fund Management Co., Ltd.	8,179,177	-949,000
0.36752 %	Harvest Fund Management Co., Ltd.	7,755,732	5,577,800
0.36286 %	China Asset Management Co., Ltd.	7,657,452	-4,477,756
0.21662 %	The Vanguard Group, Inc.	4,571,302	487,300
0.13266 %	HuaAn Fund Management Co., Ltd.	2,799,504	-59,500
0.12878 %	BlackRock Advisors (UK) Limited	2,717,560	72,500
0.10085 %	BlackRock Institutional Trust Company, N.A.	2,128,189	27,500
0.07728 %	Hwabao WP Fund Management Co., Ltd.	1,630,800	-84,800
0.07160 %	Guotai Asset Management Co., Ltd.	1,510,960	24,200
0.06540 %	Wu (Yifang)	1,380,100	0
0.06287 %	Galaxy Asset Management Co., Ltd.	1,326,684	313,400
0.05848 %	Rongtong Fund Management Co., Ltd.	1,234,200	1,234,200
0.04526 %	Fullgoal Fund Management Co., Ltd.	955,182	-3,850,100
0.04497 %	Handelsbanken Kapitalf¿rvaltning AB	948,900	40,000
0.04488 %	Fortune & Royal Asset Management Company Limited	947,000	132,000
0.04148 %	Penghua Fund Management Co., Ltd.	875,300	-1,206,391
0.03989 %	ICBC Credit Suisse Asset Management Co. Ltd.	841,834	90,400
0.03659 %	China Asset Management (Hong Kong) Limited	772,240	-77,200
0.03612 %	AEGON-INDUSTRIAL Fund Management Co., Ltd.	762,200	224,200
0.03607 %	Essence Fund Management Co., Ltd.	761,102	-198,000
0.03390 %	Amundi Asset Management, SAS	715,460	13,400
0.03307 %	Harvest Global Investments Limited	697,814	-4,500
0.03171 %	China Southern Asset Management Co. Ltd.	669,151	78,300
0.03029 %	DWS Investments UK Limited	639,146	-22,673
0.02229 %	CPIC Fund Management Co., Ltd.	470,454	248,900
0.02216 %	Wang (Ke Xin)	467,700	0
0.02172 %	Yao (Fang)	458,300	0
0.02015 %	State Street Global Advisors (US)	425,254	-3,739
0.01981 %	Guan (Xiao Hui)	418,100	0
0.01945 %	Mellon Investments Corporation	410,477	0
0.01896 %	BlackRock (Singapore) Limited	400,179	-2,448
0.01734 %	Zhong Ou Asset Management Co., Ltd.	365,900	241,600
0.01651 %	CITIC Prudential Fund Management Co., Ltd.	348,335	-148,700
0.01548 %	Taikang Asset Management Co., Ltd.	326,705	-64,600
0.01517 %	Aviva Investors Global Services Limited	320,046	166
0.01375 %	CCB Principal Asset Management Co., Ltd.	290,146	12,000
0.01305 %	Western Leadbank Fund Management Co., Ltd.	275,329	-5,500
0.01260 %	Tibet Eastmoney Fund Management Co., Ltd.	265,900	24,700
0.01243 %	California State Teachers Retirement System	262,400	84,800
0.01242 %	JPMorgan Asset Management (China) Company Limited.	262,100	-27,200
0.01152 %	State Street Global Advisors (UK) Ltd.	243,176	-108,500
0.01078 %	Goldman Sachs Asset Management, L.P.	227,489	0
0.01076 %	Wen (Deyong)	227,100	0
0.01053 %	Cardano Asset Management NV	222,285	2,501
0.01030 %	China Life AMP Asset Management Co., Ltd	217,300	9,700
0.00980 %	Geode Capital Management, L.L.C.	206,900	-300
0.00920 %	SWS MU Fund Management Co., Ltd.	194,052	-21,400
0.00911 %	UBS Asset Management (UK) Ltd.	192,300	0
0.00882 %	Huashang Fund Management Co., Ltd.	186,100	186,100
0.00876 %	BlackRock Investment Management (UK) Ltd.	184,800	0
0.00872 %	Nuveen LLC	183,988	0
0.00861 %	Krane Funds Advisors, LLC	181,629	-3,000
0.00827 %	Northern Trust Global Investments Limited	174,600	300
0.00782 %	First Seafront Fund Management Co., Ltd.	164,951	-50,300
0.00764 %	Charles Schwab Investment Management, Inc.	161,200	0
0.00704 %	PGGM Vermogensbeheer B.V.	148,597	31,105
0.00662 %	LBP AM	139,804	-37,273
0.00648 %	DWS Investment GmbH	136,775	-2,400
0.00646 %	UBS Fund Management (Switzerland) AG	136,312	-8,600
0.00628 %	HSBC Global Asset Management (UK) Limited	132,517	8,100
0.00576 %	JP Morgan Asset Management	121,500	0
0.00557 %	Fubon Asset Management Company Ltd.	117,545	-1,100
0.00541 %	Z¿rcher Kantonalbank (Asset Management)	114,200	0
0.00541 %	Hony Horizon Fund Management Co., Ltd.	114,100	-6,900
0.00541 %	Chen (Qi Yu)	114,075	0
0.00538 %	Li (Jing)	113,500	0
0.00538 %	Feng (Rongli)	113,500	0
0.00538 %	Wang (Donghua)	113,500	0
0.00525 %	Amundi Japan Ltd.	110,850	-4,500
0.00489 %	Mercer Global Investments Management Ltd	103,200	0
0.00472 %	Pictet Asset Management Ltd.	99,600	0
0.00427 %	Changsheng Fund Management Co., Ltd.	90,164	7,300
0.00425 %	Nykredit Bank AS	89,601	48,901
0.00418 %	Caitong Fund Management Co., Ltd.	88,200	1,100
0.00415 %	BOCI-Prudential Asset Management Ltd.	87,500	0
0.00403 %	UBS Asset Management (Switzerland)	85,000	0
0.00390 %	ABC-CA Fund Management Co., Ltd.	82,242	-2,200
0.00388 %	Dong (Xiao Xian)	81,800	0
0.00381 %	Mei (Jing Ping)	80,300	0
0.00360 %	Nuode Asset Management Company Limited	76,000	-77,200
0.00358 %	Bosera Asset Management Co., Ltd.	75,500	-219,700
0.00346 %	Legal & General Investment Management Ltd.	73,100	0
0.00333 %	Xu (Aihua)	70,200	0
0.00322 %	Wanjia Asset Management Co., Ltd.	68,049	-3,600
0.00320 %	CICC Fund Management Co Ltd.	67,600	13,000
0.00317 %	Liu (Yi)	66,800	0
0.00317 %	Li (Dongjiu)	66,800	46,800
0.00317 %	Bao (Qingui)	66,800	0
0.00293 %	Mirae Asset Global Investments (Hong Kong) Limited	61,854	7,400
0.00282 %	Franklin Advisers, Inc.	59,600	10,000
0.00269 %	Zhu (Yue)	56,800	0

What values and corporate philosophy does Shanghai Fosun Pharmaceutical Group Co represent?

Shanghai Fosun Pharmaceutical Group Co Ltd represents a set of core values and a strong corporate philosophy. With a focus on innovation, integrity, and social responsibility, the company strives to deliver high-quality pharmaceutical products and healthcare services. Shanghai Fosun Pharmaceutical Group Co Ltd believes in fostering sustainable development and prioritizes the well-being of patients and the community. The company's dedication to excellence, patient-centric approach, and continuous research and development efforts make it a prominent player in the pharmaceutical industry. Shanghai Fosun Pharmaceutical Group Co Ltd exemplifies a commitment to quality, ethical practices, and making a positive impact on society.

In which countries and regions is Shanghai Fosun Pharmaceutical Group Co primarily present?

The Shanghai Fosun Pharmaceutical Group Co Ltd primarily operates and has a significant presence in multiple countries and regions. The company is mainly active in China, where its headquarters is located. It also has a strong presence in various other regions and countries, including the United States, Europe, India, and Africa. Shanghai Fosun Pharmaceutical Group Co Ltd focuses on expanding its global footprint through strategic partnerships, collaborations, and acquisitions. With its diversified portfolio and global operations, the company continues to deliver innovative healthcare solutions and contribute to the well-being of people worldwide.

What significant milestones has the company Shanghai Fosun Pharmaceutical Group Co achieved?

Shanghai Fosun Pharmaceutical Group Co Ltd has achieved several significant milestones in its history. The company has demonstrated consistent growth and expansion, becoming one of the leading pharmaceutical companies in China. It has successfully developed and marketed various innovative drugs, contributing to improved healthcare outcomes for patients. Shanghai Fosun Pharmaceutical Group Co Ltd has also made strategic acquisitions and formed partnerships to strengthen its market presence both domestically and internationally. Additionally, the company has received recognition for its commitment to research and development, as well as its contributions to healthcare philanthropy. These achievements make Shanghai Fosun Pharmaceutical Group Co Ltd a formidable player in the pharmaceutical industry.

What is the history and background of the company Shanghai Fosun Pharmaceutical Group Co?

Shanghai Fosun Pharmaceutical Group Co Ltd, commonly known as Fosun Pharma, is a leading Chinese pharmaceutical company. Established in 1994, the company has a rich history and a strong background in the healthcare industry. Fosun Pharma focuses on research, development, manufacturing, and distribution of a wide range of pharmaceutical products, including prescription drugs, over-the-counter medicines, and medical devices. Over the years, Fosun Pharma has expanded its presence globally and has become one of the largest comprehensive healthcare groups in China. With a commitment to innovation and high-quality products, Shanghai Fosun Pharmaceutical Group Co Ltd continues to make significant contributions to the advancement of healthcare worldwide.

Who are the main competitors of Shanghai Fosun Pharmaceutical Group Co in the market?

The main competitors of Shanghai Fosun Pharmaceutical Group Co Ltd in the market include multinational pharmaceutical companies such as Johnson & Johnson, Pfizer, Novartis, and GlaxoSmithKline. These competitors are well-established players in the global pharmaceutical industry and offer a wide range of products and services similar to Shanghai Fosun Pharmaceutical Group. As Shanghai Fosun Pharmaceutical Group aims to expand globally and capture a larger market share, it faces strong competition from these industry giants. However, Shanghai Fosun Pharmaceutical Group has its unique strengths, product portfolio, and innovative strategies to differentiate itself and gain a competitive advantage in the market.

In which industries is Shanghai Fosun Pharmaceutical Group Co primarily active?

Shanghai Fosun Pharmaceutical Group Co Ltd is primarily active in the pharmaceutical industry.

What is the business model of Shanghai Fosun Pharmaceutical Group Co?

The business model of Shanghai Fosun Pharmaceutical Group Co Ltd focuses on various aspects of the pharmaceutical industry. As a leading healthcare company, it engages in research and development, manufacturing, sales, and distribution of pharmaceutical products. Shanghai Fosun Pharmaceutical Group Co Ltd is committed to promoting innovation and improving the accessibility of healthcare products and services. It operates through segments such as pharmaceutical manufacturing, research and development, distribution and retail, and medical services. By leveraging its strong industry expertise and strategic partnerships, Shanghai Fosun Pharmaceutical Group Co Ltd aims to contribute to the advancement of healthcare and provide high-quality medical solutions to customers worldwide.

Shanghai Fosun Pharmaceutical Group Co 2024의 P/E 비율은 얼마입니까?

Shanghai Fosun Pharmaceutical Group Co의 P/E 비율은 30.58입니다.

Shanghai Fosun Pharmaceutical Group Co 2024의 KUV는 얼마입니까?

Shanghai Fosun Pharmaceutical Group Co의 P/S 비율은 1.65입니다.

Shanghai Fosun Pharmaceutical Group Co의 AlleAktien 품질 점수는 얼마인가요?

Shanghai Fosun Pharmaceutical Group Co에 대한 AlleAktien 품질 점수는 3/10입니다.

Shanghai Fosun Pharmaceutical Group Co 2024의 매출은 얼마인가요?

예상되는 Shanghai Fosun Pharmaceutical Group Co 매출은 42.86 조. CNY입니다.

Shanghai Fosun Pharmaceutical Group Co 2024의 이익은 얼마인가요?

예상되는 Shanghai Fosun Pharmaceutical Group Co 이익은 2.31 조. CNY입니다.

Shanghai Fosun Pharmaceutical Group Co은 무엇을 하나요?

The Shanghai Fosun Pharmaceutical Group Co Ltd is a leading company in the development, manufacturing, and marketing of pharmaceutical products and medical services. The business model is based on a diversified portfolio of business activities focused on various segments of the healthcare industry. The company's first division is the manufacturing of pharmaceutical products. Shanghai Fosun Pharma produces a wide range of medical products, including drugs, diagnostics, and medical devices. The company specializes in innovative drug manufacturing to offer high-quality medical solutions to its customers, with a strong emphasis on product quality. Another important division is research and development. Shanghai Fosun Pharma invests significantly in researching and developing new drugs and therapies. The company collaborates closely with international partners to develop innovative technologies and products that meet market needs. In addition to these activities, the company also operates hospitals, healthcare centers, and care facilities. Shanghai Fosun Pharma is a leading provider of high-quality healthcare services in China. The company strives to offer its customers a comprehensive range of services focused on the needs of patients. Furthermore, the group also has a subsidiary, Fosun Industrial Co Ltd, specializing in the manufacturing and marketing of chemicals and plastic products. This perfectly complements the company's portfolio and enables it to serve more customers. The company also offers various health products, including dietary supplements, medical aids, and wellness products. These products are sold in the company's own pharmacies as well as retail pharmacies nationwide. Shanghai Fosun Pharma also operates in overseas markets, with branches in various countries around the world. The company aims to bring product quality and innovation to the global market in order to make them accessible to an even larger part of society. In summary, the business model of Shanghai Fosun Pharmaceutical Group Co Ltd is based on innovation and differentiation through research and development, manufacturing, and distribution of drugs, medical services, and products. The company has a strong presence in the healthcare market and delivers world-leading products and services.

Shanghai Fosun Pharmaceutical Group Co 배당금은 얼마입니까?

Shanghai Fosun Pharmaceutical Group Co은(는) 연간 번의 배당을 통해 0.56 CNY의 배당금을 지급합니다.

Shanghai Fosun Pharmaceutical Group Co이 얼마나 자주 배당을 지급하나요?

Shanghai Fosun Pharmaceutical Group Co의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Shanghai Fosun Pharmaceutical Group Co ISIN이 무엇입니까?

Shanghai Fosun Pharmaceutical Group Co의 ISIN은 CNE000000X38입니다.

Shanghai Fosun Pharmaceutical Group Co 티커는 무엇인가요?

Shanghai Fosun Pharmaceutical Group Co의 티커는 600196.SS입니다.

Shanghai Fosun Pharmaceutical Group Co이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 Shanghai Fosun Pharmaceutical Group Co은(는) 0.42 CNY 의 배당금을 지급했습니다. 이는 약 1.58 %의 배당 수익률에 해당합니다. 향후 12개월 동안 Shanghai Fosun Pharmaceutical Group Co은(는) 0.44 CNY의 배당금을 지급할 것으로 예상됩니다.

Shanghai Fosun Pharmaceutical Group Co의 배당 수익률은 얼마입니까?

Shanghai Fosun Pharmaceutical Group Co의 현재 배당 수익률은 1.58 %입니다.

Shanghai Fosun Pharmaceutical Group Co의 배당금은 언제 지급되나요?

Shanghai Fosun Pharmaceutical Group Co은 분기별로 배당금을 지급합니다. 이는 , , , 월에 배당됩니다.

Shanghai Fosun Pharmaceutical Group Co의 배당금은 얼마나 안전한가요?

Shanghai Fosun Pharmaceutical Group Co은(는) 지난 23년 동안 매년 배당금을 지급했습니다.

Shanghai Fosun Pharmaceutical Group Co의 배당금은 얼마입니까?

향후 12개월 동안 0.44 CNY의 배당금이 예상됩니다. 이는 배당수익률 1.67 %에 해당합니다.

Shanghai Fosun Pharmaceutical Group Co이(가) 속해 있는 섹터는 어디인가요?

Shanghai Fosun Pharmaceutical Group Co은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von Shanghai Fosun Pharmaceutical Group Co kaufen, um die vorherige Dividende zu erhalten?

Shanghai Fosun Pharmaceutical Group Co의 마지막 배당금을 0.27 CNY만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

Shanghai Fosun Pharmaceutical Group Co의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

Shanghai Fosun Pharmaceutical Group Co의 2023년도 배당금은 얼마였습니까?

2023년에 Shanghai Fosun Pharmaceutical Group Co는 0.56 CNY를 배당금으로 지급했습니다.

Shanghai Fosun Pharmaceutical Group Co는 어떤 화폐로 배당금을 지급하나요?

Shanghai Fosun Pharmaceutical Group Co의 배당금은 CNY에 지급됩니다.

1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0.03	0.33	0.18	0.34	0.37	0.63	1.24	0.69	0.75	0.99	1.08	1.01	1.31	3.56	3.13	5.2	3.11	3.73	4.13	6.05	7.47	9.16	9.99	11.93	13.58	16.94	15.33
0.05	0.05	0.1	0.12	0.17	0.24	0.3	0.39	0.46	0.48	0.45	0.45	0.56	0.84	0.93	0.91	1.29	1.5	1.74	1.97	3.25	3.62	4.37	4.57	6.03	7.59	7.79
0.08	0.05	0.03	0.09	0.13	0.14	0.22	0.11	0.12	0.27	0.22	0.35	0.23	0.42	0.66	0.76	0.76	0.69	0.62	0.8	1.28	1.42	1.58	1.81	2.01	1.55	1.91
0.05	0.05	0.1	0.08	0.12	0.36	0.31	0.47	0.53	0.61	0.5	0.53	0.6	0.93	1.12	1.27	1.61	1.61	1.65	1.67	2.75	3.29	3.94	5.16	5.47	6.88	7.54
0.01	0.03	0.06	0.03	0.26	0.05	0.03	0.1	0.1	0.07	0.27	0.08	0.61	0.16	0.22	0.24	0.21	1.14	0.19	0.29	0.31	0.5	0.53	1.61	3.33	2.32	1.23
0.22	0.51	0.47	0.66	1.05	1.41	2.1	1.76	1.96	2.42	2.52	2.42	3.31	5.91	6.05	8.38	6.99	8.67	8.33	10.77	15.06	18	20.4	25.09	30.42	35.28	33.79
0.04	0.07	0.2	0.24	0.35	0.57	0.78	1.05	1.24	1.26	1.14	1.15	1.26	1.69	2.63	3.57	5.06	5.84	5.92	6.39	8.41	9.37	11.43	13.26	14.44	17.4	23.67
0.02	0.05	0.21	0.58	0.77	1.03	1.18	2.12	2.24	2.59	3.47	3.68	6.66	8.18	10.24	10.05	11.61	14.41	17.23	18.85	21.12	24.06	23.02	23.77	23.92	25.55	25.01
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	189	77.4	212.8	282.07
0	0	0.02	0.03	0.04	0.1	0.1	0.18	0.2	0.21	0.21	0.2	0.21	0.53	1.71	1.78	2.64	2.91	3.25	3.65	8.28	9.19	10.97	11.5	13.43	15.93	17.38
0	0	0	0	0	0	0	0	0	0.05	0.05	0.05	0.05	0.34	1.59	1.66	2.98	3.26	3.3	3.47	8.46	8.85	9.01	8.68	9.4	10.34	10.85
0.01	0.01	0.02	0.02	0.01	0.04	0.05	0.03	0.03	0.06	0.05	0.04	0.04	0.18	0.08	0.06	0.21	0.26	0.18	0.64	0.64	1.07	1.29	1.21	1.59	2.47	2.48
0.07	0.13	0.44	0.87	1.17	1.74	2.1	3.39	3.71	4.18	4.92	5.12	8.22	10.92	16.24	17.13	22.49	26.67	29.88	33	46.92	52.55	55.72	58.6	62.87	71.88	79.68
0.29	0.64	0.92	1.53	2.22	3.15	4.21	5.15	5.67	6.59	7.44	7.54	11.53	16.83	22.29	25.51	29.47	35.34	38.2	43.77	61.97	70.55	76.12	83.69	93.29	107.16	113.47

0.06	0.15	0.23	0.29	0.29	0.38	0.38	0.83	0.83	0.95	1.24	1.24	1.24	1.9	1.9	2.24	2.24	2.31	2.31	2.42	2.5	2.56	2.56	2.56	2.56	2.67	2.67
0	0.3	0.22	0.67	0.73	0.69	0.72	0.76	0.82	1.48	1.49	1.06	1.16	1.83	2.21	4.29	6.28	6.15	6.06	7.86	9.08	10.55	12.14	15.13	14.03	16.99	16.85
0.05	0.06	0.16	0.15	0.25	0.4	0.59	0.71	0.74	0.61	1.14	1.71	4.08	4.69	5.67	7.04	5.63	7.12	8.93	11.12	13.37	15.15	17.65	20.23	23.87	26.17	27.5
0	0	0	0	0	0	0	0	-0	0	0	0	0	-0	-0.01	-0.01	1.18	1.12	0.92	0.83	0.4	-0.28	-0.47	-0.93	-1.38	-1.18	-1.06
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	113.9	-18.79	-236.87
0.1	0.51	0.6	1.11	1.27	1.47	1.69	2.29	2.39	3.05	3.87	4.01	6.48	8.42	9.77	13.56	15.33	16.7	18.23	22.22	25.34	27.98	31.89	37	39.19	44.64	45.73
0.05	0.04	0.07	0.07	0.09	0.32	0.32	0.41	0.47	0.41	0.27	0.36	0.46	0.73	0.76	0.78	0.99	0.83	0.97	1.03	1.65	2.18	2.15	2.94	4.52	5.43	5.51
0	0.01	0.01	0.01	0.01	0.04	0.04	0.07	0.06	0.09	0.05	0.08	0.07	0.11	0.21	0.31	0.48	0.59	0.61	0.75	0.88	1.03	0.98	1.13	1.51	1.89	2.33
0.08	0.03	0.07	0.11	0.13	0.2	0.32	0.28	0.3	0.26	0.25	0.28	0.35	0.93	1.66	1.3	2.24	3.09	1.94	2.06	3.47	4.03	5.14	5.22	6.41	7.3	5.33
0.02	0	0.06	0.13	0.63	0.78	0.48	0.75	0.87	1.45	1.46	0.98	1.11	1.88	1.78	1.15	1.53	3.91	5.55	4.45	9.85	5.76	6.6	8.66	11.75	13.27	15.84
0	0	0	0	0	0	0	0	0.01	0.14	0.18	0.06	0.5	0.06	0.59	0.36	0.04	1.11	1.86	1.82	0.76	4.93	2.56	6.92	5.13	5.41	4.75
0.15	0.07	0.22	0.32	0.86	1.34	1.17	1.51	1.71	2.34	2.22	1.76	2.5	3.7	4.99	3.89	5.28	9.54	10.94	10.11	16.6	17.92	17.43	24.87	29.31	33.3	33.76
0	0.03	0	0.03	0.03	0.05	1.02	0.75	0.98	0.55	0.75	1.18	1.29	2.76	3.92	4.28	4.2	3.88	3.59	5.58	9.82	12.69	12.99	9.34	9.9	13.04	15.89
0	0	0	0	0	0	0	0	0	0	0.07	0.08	0.7	0.87	1.6	1.36	1.78	1.93	1.85	1.79	2.98	2.91	2.99	2.85	3.13	3.36	3.45
0	0.01	0.01	0	0	0.01	0.01	0.11	0.1	0.1	0.09	0.08	0.09	0.1	0.42	0.67	0.55	0.89	1.16	1.04	2.83	3.44	3.5	0.64	2.57	3.36	3.76
0	0.04	0.01	0.03	0.03	0.05	1.03	0.86	1.09	0.64	0.9	1.34	2.08	3.72	5.93	6.31	6.53	6.7	6.59	8.41	15.63	19.04	19.48	12.83	15.61	19.76	23.1
0.15	0.12	0.23	0.35	0.88	1.39	2.2	2.37	2.79	2.98	3.12	3.09	4.58	7.42	10.92	10.2	11.81	16.23	17.53	18.52	32.23	36.96	36.92	37.7	44.92	53.05	56.85
0.26	0.63	0.84	1.46	2.16	2.86	3.89	4.66	5.19	6.03	6.99	7.1	11.05	15.84	20.69	23.76	27.14	32.93	35.76	40.74	57.57	64.94	68.81	74.7	84.11	97.69	102.58

1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.95
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	2.34
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	50	-188
66	-37	-52	-107	-150	-199	-308	-347	-341	-497	-470	-570	-535	-1,220	-2,103	-3,171	-3,721	-4,956	-5,976	-7,424	-11,359	-13,569	-12,871	-15,073	-18,041
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-2,996	-572
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-14	-24	-14	-40	-65	-129	-239	-205	-185	-184	-209	-336	-363	-616	-755	-963	-1,171	-1,395	-1,560	-1,959	-2,410	-2,275	-2,196	-1,836	-1,609
0.07	0.04	0.14	0.07	0.1	0.15	0.21	0.19	0.18	0.13	0.23	0.26	0.2	0.32	0.67	1.01	1.2	1.62	2.11	2.58	2.95	3.22	2.58	3.95	4.22
-52	-78	-126	-141	-139	-264	-205	-222	-266	-209	-210	-348	-339	-796	-1,160	-1,040	-1,119	-1,235	-1,922	-2,170	-3,174	-3,962	-4,437	-4,972	-5,888
-99	-238	-443	-487	-150	162	-779	-437	-336	-53	56	-397	-264	-1,766	-978	-1,803	-2,478	-1,869	-2,447	-10,504	-5,244	-172	-4,706	-3,856	-4,064
-0.05	-0.16	-0.32	-0.35	-0.01	0.43	-0.57	-0.22	-0.07	0.16	0.27	-0.05	0.07	-0.97	0.18	-0.76	-1.36	-0.63	-0.53	-8.33	-2.07	3.79	-0.27	1.12	1.82
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-0.02	0.01	0.08	0.5	0.09	-0.29	0.16	0.35	0.8	0.38	-0.09	0.68	1.72	1.52	-0.46	-0.03	3.09	2	0.57	8.93	2.39	-2.44	2.25	1.81	3.75
372	77	435	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.34	0.04	0.47	0.45	0.02	0.59	0.01	0.15	0.37	0.14	-0.35	0.4	1.82	0.91	2.07	-0.93	1.86	0.55	1.45	9.91	3.14	-1.94	1.47	-0.83	4.43
-0	-0.03	-0.04	0.04	0.02	0.98	0.01	0.03	-0	0.02	0.02	0.02	0.48	-0.06	3.23	0.15	-0.1	-0.34	2.07	2.41	4.3	2.37	1.05	-0.73	3.06
-7	-10	-4	-84	-91	-105	-149	-228	-428	-258	-277	-302	-378	-543	-707	-1,058	-1,126	-1,109	-1,193	-1,433	-3,551	-1,864	-1,834	-1,913	-2,374
0.32	-0.06	0.37	0.25	0.29	1.38	0.19	0.64	0.93	1.03	0.85	1.43	2.86	1.61	5.27	3.39	6.69	8.31	10.84	13.78	17.55	20.18	16.69	19.98	28.58
14.4	-39.8	11.8	-73.3	-37	-114	0.1	-34.3	-81.7	-78.2	22.4	-86.2	-135.8	-480.2	-495.1	-28.5	80.8	385.5	188	409.6	-224.8	-739.7	-1,857.3	-1,023.84	-1,671.27
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Scope 1 - 직접 방출	210,819
스코프 2 - 구매한 에너지로부터의 간접적인 배출	677,874
Scope 3 - 가치 창출 체인 내의 간접 배출	72,171
총 CO₂ 배출량	888,693
CO₂ 감소 전략
석탄 에너지
원자력
동물 실험
펠츠 & 레더
살충제
팜 오일
담배
유전자 변형 생물체
기후 개념
지속 가능한 임업
재활용 규정
환경 친화적인 포장
위험물질
연료 소비량과 효율성
물 사용량 및 효율성

여성 직원 비율	49.529
관리 직위에서의 여성 비율
아시아 직원 비율
아시아 경영진 비율
히스패닉/라티노 직원 비율
히스패닉/라티노 관리 부문 지분
흑인 직원 비율
블랙 매니지먼트 지분
흰색 종업원의 비율
화이트 매니지먼트 지분
성인 콘텐츠
알코올
무기
총기
도박
군사 계약
인권 개념
개인정보 보호 정책
작업 및 건강 보호
카톨릭

환경 보고
이해관계자 참여
콜백 정책
카르텔법

1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
0.19	0.34	0.49	0.57	0.73	1.03	2.16	2.43	2.99	4.08	3.69	3.77	3.87	4.56	6.49	7.34	10	12.03	12.61	14.63	18.53	24.92	28.59	30.31	39.01	43.95	41.4	42.86	46.62	48.72
-	78.95	43.24	16.43	28.40	41.76	108.82	12.53	23.26	36.57	-9.53	2.17	2.62	17.64	42.39	13.18	36.17	20.31	4.85	16.02	26.69	34.44	14.72	6.02	28.70	12.68	-5.81	3.53	8.77	4.51
36.84	37.06	42.71	43.56	37.23	34.40	26.91	31.22	29.98	21.34	26.59	27.67	32.02	33.90	37.63	43.62	44.22	43.87	49.78	53.81	58.84	58.34	59.57	55.47	47.97	47.09	47.54	-	-	-
0.07	0.13	0.21	0.25	0.27	0.36	0.58	0.76	0.9	0.87	0.98	1.04	1.24	1.54	2.44	3.2	4.42	5.28	6.28	7.87	10.91	14.54	17.03	16.81	18.71	20.7	19.68	0	0	0
0.05	0.07	0.11	0.1	0.08	0.07	0.06	0.15	0.14	0.09	0.16	0.12	0.16	0.16	0.32	0.55	1.03	1.11	1.36	1.64	2.24	2.29	2.49	2.64	2.55	3.5	1.29	2.86	3.15	3.26
27.37	20.88	21.77	17.11	10.44	6.88	2.92	6.31	4.78	2.25	4.44	3.13	4.05	3.58	5.00	7.53	10.30	9.19	10.81	11.23	12.06	9.17	8.71	8.72	6.54	7.97	3.10	6.68	6.76	6.69
0.04	0.06	0.09	0.1	0.14	0.15	0.26	0.22	0.16	0.26	0.63	0.69	2.5	0.86	1.17	1.56	1.58	2.11	2.46	2.81	3.12	2.71	3.32	3.66	4.74	3.73	2.39	2.31	2.76	3.23
-	55.00	50.00	10.75	38.83	2.80	76.19	-16.99	-26.05	62.26	142.64	10.38	261.51	-65.41	34.95	34.13	1.21	33.48	16.42	14.07	11.33	-13.32	22.67	10.26	29.27	-21.22	-36.03	-3.02	19.19	17.01
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0.55	1.42	1.42	1.49	1.49	1.49	1.49	1.61	1.62	1.86	1.86	1.86	1.86	1.89	1.9	2.24	2.24	2.3	2.32	2.33	2.46	2.52	2.56	2.56	2.56	2.61	2.67	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Shanghai Fosun Pharmaceutical Group Co 티커	Shanghai Fosun Pharmaceutical Group Co FIGI
600196:CH	BBG000C4SR52
600196:CG	BBG000C4SRF1
600196:C1	BBG00709HHX2

한 눈에 저평가된 주식을 인식하세요

가격

가격

티커600196.SS

ISINCNE000000X38

Shanghai Fosun Pharmaceutical Group Co 주식 가격

가격

개요

인트라데이 기능

총 수익률 및 상대 가격 변동

해석 및 투자

Shanghai Fosun Pharmaceutical Group Co 주가 이력

Shanghai Fosun Pharmaceutical Group Co 주식 매출, EBIT, 이익 CNE000000X38 ·

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

Shanghai Fosun Pharmaceutical Group Co 매출, 이익 및 EBIT 역사

Shanghai Fosun Pharmaceutical Group Co 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

Shanghai Fosun Pharmaceutical Group Co 주식 마진 CNE000000X38 ·

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

Shanghai Fosun Pharmaceutical Group Co 마진 역사

Shanghai Fosun Pharmaceutical Group Co 주식 매출, EBIT, 주당 순이익 CNE000000X38 ·

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Shanghai Fosun Pharmaceutical Group Co 매출, 이익 및 EBIT 주당 역사

Shanghai Fosun Pharmaceutical Group Co 주식 및 주식 분석

Shanghai Fosun Pharmaceutical Group Co Fair Value에 따른 평가

Fair Value

Fair Value 이해하기

수익 기반 Fair Value

매출 기반 Fair Value

배당 기반 Fair Value

기대치와 예측

비교 분석

Shanghai Fosun Pharmaceutical Group Co 역사적인 P/E, EBIT 및 P/S에 따른 평가

Shanghai Fosun Pharmaceutical Group Co 주식 수량 CNE000000X38 ·

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Shanghai Fosun Pharmaceutical Group Co 주식 분할

Shanghai Fosun Pharmaceutical Group Co 주식 배당금 CNE000000X38 ·

배당금

배당금에 대한 개요

해석 및 사용

투자 전략

Shanghai Fosun Pharmaceutical Group Co 배당금 내역

Shanghai Fosun Pharmaceutical Group Co 주식 배당률 CNE000000X38 ·

배당비율

연간 배당비율이란 무엇인가요?

데이터 해석 방법

투자에 대한 데이터 사용

Shanghai Fosun Pharmaceutical Group Co 배당금지급률 역사

한눈에 과소평가된 주식을 인식하세요.

티커
600196.SS

ISIN
CNE000000X38